Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Molecular Factors Contributing to Cancer-associated Muscle Mass Loss and Providing Clinical Evidence for Exercise Mechanisms to Functionally Restore Muscle in Cancer

NCT05307367 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT05307367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05307367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Molecular Factors Contributing to Cancer-associated Muscle Mass Loss and Providing Clinical Evidence for Exercise Mechanisms to Functionally Restore Muscle in Cancer
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2022
Completion date
January 1, 2028
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adipose tissue, body composition, cachexia, caregivers, epigenomics, exercise, gastrointestinal microbiome, insulin resistance, lipidomics, metabolism, mitochondria, muscle, skeletal, neoplasms, patient reported outcome measures, physical functional performance, proteomics, quality of life, sarcopenia